Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER_GOV × daratumumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 36 OTHER 22 NETWORK 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Gemcitabine 14 Radiotherapy 10 Cisplatin 10 Metformin 8 Paclitaxel 7 Fluorouracil 7 Oxaliplatin 6 Indocyanine Green 6 Exercise 6 Docetaxel 6 Control Groups 6 Capecitabine 6 Surveys and Questionnaires 5 Standard of Care 5 Letrozole 5 Cyclophosphamide 5 Zoledronic Acid 4 Vinorelbine 4 Saline Solution 4 Preoperative Exercise 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Irinotecan 4 Ifosfamide 4 Gefitinib 4 Drug Therapy 4 Carboplatin 4 pembrolizumab 3 Trastuzumab 3 Tranexamic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065789 2022-01-27

KyDaR

Tel-Aviv Sourasky Medical Center

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡